The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.10, Iss.6, 2010-12, pp. : 369-382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Cholesterol-Lowering Therapies in Spain

By Plans-Rubió Pedro

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 177-188

Adis International

Access to resources Recommend Favorite

Spain touts generics as reference pricing due

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 292, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis for Statin Therapies in the Primary Prevention of Coronary Heart Disease in Italy

By Berto P.

Clinical Drug Investigation, Vol. 20, Iss. 2, 2000-08 ,pp. : 109-121

Adis International

Access to resources Recommend Favorite

Spain's reference price system introduced in the wake of generics rise

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 293, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Cost effectiveness of intensive statin therapy remains debatable

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 595, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite